Fig. 3.
One mechanism of granzyme B–independent cytotoxicity involving the Fas pathway. Allospecific day 5 MLR-derived CTLs (H-2b anti–H-2d) from granzyme B+/+ (B+/+), granzyme B−/− (B−/−), and granzyme B−/− × gld/gld (B−/− × g/g) spleens were used against allogeneic TA3 (H-2d) lymphoma cells at a fixed E:T ratio of 10:1 in 51Cr release (A) and 125IUdR release (B) assays. Note that granzyme B−/− and granzyme B−/− × gld/gld CTLs induce essentially normal levels of 51Cr release, whereas both effector populations are unable to mediate any 125I-labeled DNA release at early time points. However, the defective 125I-labeled DNA release is more severe in granzyme B−/− × gld/gld cells than in CTLs deficient for granzyme B alone. Error bars show the range of values at each point. This experiment represents one of four with similar results.